title: [What technique for what tumor? Ethical and methodological issues: cervical cancer].
abstract: Cancers of the uterus are on the list of cancer sites for which the interest of the use of conformal radiotherapy with intensity modulation is being evaluated by the French Health Authority. In 2014, many consider that many challenges still lie ahead for the integration of this technique in routine management of cervical cancer on intact uterus. These challenges, are they really a barrier to diffusion of this technique for a tumor location where the radiation keeps an important role? The purpose of this review is to discuss, in terms of the risk-benefit balance, the prescription of intensity-modulated radiotherapy compared to non-modulated three-dimensional conformal radiotherapy.
authors.affiliation: Centre régional de cancérologie H.S.-Kaplan, clinique d'oncologie et radiothérapie, hôpital Bretonneau, CHU de Tours, 2, boulevard Tonnellé, 37000 Tours, France; Université François-Rabelais, 37000 Tours, France. Electronic address: i.barillot@chu-tours.fr.
authors.forename: I
authors.initials: I
authors.lastname: Barillot
mesh_terms: D001853:Bone Marrow / Q000528:radiation effects; D059248:Chemoradiotherapy; D019468:Disease Management; D005260:Female; D006801:Humans; D015201:Meta-Analysis as Topic; D058958:Organs at Risk; D011832:Radiation Injuries / Q000209:etiology / Q000517:prevention & control; D011874:Radiometry; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D020266:Radiotherapy, Conformal / Q000009:adverse effects / Q000941:ethics / Q000379:methods*; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects / Q000941:ethics / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012007:Rectum / Q000528:radiation effects; D012189:Retrospective Studies; D018570:Risk Assessment; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy* / Q000628:therapy; D014599:Uterus / Q000528:radiation effects
keywords: Benefit; Bénéfice; Cancer du col utérin; Cervix carcinoma; IMRT; RCMI; Risk; Risques